US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Madrigal Pharmaceuticals, Inc. | $545.36 | 3% | $12.57B | -42.4 | 29.1% | — | Healthcare | 88.6% | 256.8% | ||
| 2 | Rhythm Pharmaceuticals, Inc. | $114.46 | 2.5% | $7.84B | -36.8 | -13% | — | Healthcare | 72.4% | 58.7% | ||
| 3 | Metsera, Inc. | $70.50 | 0% | $7.43B | -34.7 | — | — | Healthcare | 148.3% | — | ||
| 4 | Viking Therapeutics, Inc. | $42.13 | 8.8% | $4.88B | -13.2 | -260% | — | Healthcare | 53.1% | — | ||
| 5 | Terns Pharmaceuticals, Inc. | $52.95 | 0% | $4.77B | -51.4 | 8.8% | — | Healthcare | 1223.8% | — | ||
| 6 | Akero Therapeutics, Inc. | $54.65 | 0% | $4.5B | -14.6 | 0.3% | — | Healthcare | 6.1% | — | ||
| 7 | NewAmsterdam Pharma Company N.V. | $36.99 | 6% | $4.32B | -21.1 | 5.2% | — | Healthcare | 90.1% | -52.1% | ||
| 8 | Structure Therapeutics Inc. | $56.63 | 3.4% | $3.26B | -23.6 | -2.3% | — | Healthcare | 202.3% | — | ||
| 9 | Inventiva S.A. | $4.56 | 16.9% | $2.91B | -2.2 | -45.1% | — | Healthcare | 51% | -64.6% | ||
| 10 | MBX Biosciences, Inc. Common Stock | $62.00 | 7.5% | $2.08B | -26.1 | 0% | — | Healthcare | 381.4% | — | ||
| 11 | Maze Therapeutics, Inc. | $32.84 | 1.5% | $1.82B | -10.8 | -4396.9% | — | Healthcare | 171% | -88.1% | ||
| 12 | Septerna, Inc. | $35.83 | 7.1% | $1.62B | -32.6 | 59.7% | — | Healthcare | 230.2% | 7295.6% | ||
| 13 | MannKind Corporation | $4.22 | -1.2% | $1.3B | 211.0 | -175.4% | — | Healthcare | 19.2% | 21.2% | ||
| 14 | Lexicon Pharmaceuticals, Inc. | $2.37 | 2.2% | $1.05B | -16.9 | 86% | — | Healthcare | 171.5% | 123.1% | ||
| 15 | BioAge Labs, Inc. | $24.40 | -1.8% | $919M | -10.9 | -18.2% | — | Healthcare | 483.7% | 611% | ||
| 16 | Rezolute, Inc. | $4.97 | 0.8% | $479M | -5.1 | 29.3% | — | Healthcare | -0.2% | — | ||
| 17 | Genfit S.A. | $8.95 | 4.1% | $448M | 256.9 | -212.8% | — | Healthcare | 144.5% | 9.8% | ||
| 18 | DiaMedica Therapeutics Inc. | $7.99 | -0.2% | $431M | -11.4 | -10.9% | — | Healthcare | 120.1% | — | ||
| 19 | Galectin Therapeutics Inc. | $4.61 | -0.4% | $304M | -9.6 | 43.5% | — | Healthcare | 114.4% | — | ||
| 20 | vTv Therapeutics Inc. | $34.12 | -1.2% | $287M | -10.7 | 100.6% | — | Healthcare | 129% | 216600% | ||
| 21 | Niagen Bioscience Inc | $3.45 | -1.4% | $275M | 17.3 | 26.4% | — | Healthcare | -72.3% | 20.8% | ||
| 22 | Altimmune, Inc. | $3.02 | -1.9% | $267M | -3.0 | 26.2% | — | Healthcare | -31.8% | 80% | ||
| 23 | Sagimet Biosciences Inc. | $7.69 | -0.6% | $251M | -4.9 | 23.3% | — | Healthcare | -11.4% | — | ||
| 24 | Aardvark Therapeutics, Inc. Common Stock | $5.44 | -9.2% | $119M | -2.1 | -150.8% | — | Healthcare | -60.9% | — | ||
| 25 | Entera Bio Ltd. | $1.66 | -2.9% | $82M | -6.6 | -164.2% | — | Healthcare | -9.3% | -100% | ||
| 26 | Fractyl Health, Inc. Common Stock | $0.80 | -1.2% | $57M | -0.4 | 5.4% | — | Healthcare | -48.3% | -100% | ||
| 27 | Lipocine Inc. | $2.47 | 0% | $13M | -1.5 | -94.1% | — | Healthcare | -20.6% | -45.5% | ||
| 28 | MetaVia Inc. | $1.58 | 4.6% | $3M | -0.2 | 83.7% | — | Healthcare | 154% | — | ||
| 29 | Galmed Pharmaceuticals Ltd. | $0.57 | 2.2% | $3M | -0.2 | 97% | — | Healthcare | -68.9% | — | ||
| 30 | Hepion Pharmaceuticals, Inc. | $0.06 | 0% | $698622 | -0.1 | 99.7% | — | Healthcare | -16.7% | — | ||
| 31 | XORTX Therapeutics Inc. | $2.04 | -1.4% | $568118 | -0.1 | -54.6% | — | Healthcare | -53.7% | — |
Showing 31 stocks